Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Net Cash Flow (2016 - 2025)

Orthofix Medical's Net Cash Flow history spans 16 years, with the latest figure at $19.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 64.49% year-over-year to $19.2 million, compared with a TTM value of -$2.0 million through Dec 2025, down 104.16%, and an annual FY2025 reading of -$2.0 million, down 104.16% over the prior year.
  • Net Cash Flow for Q4 2025 was $19.2 million at Orthofix Medical, up from -$2.6 million in the prior quarter.
  • The five-year high for Net Cash Flow was $54.1 million in Q4 2024, with the low at -$25.8 million in Q1 2025.
  • Average Net Cash Flow over 5 years is -$549450.0, with a median of -$1.6 million recorded in 2021.
  • Year-over-year, Net Cash Flow plummeted 1169.02% in 2022 and then surged 1516.57% in 2025.
  • Tracing OFIX's Net Cash Flow over 5 years: stood at $4.8 million in 2021, then plummeted by 142.36% to -$2.1 million in 2022, then skyrocketed by 272.01% to $3.5 million in 2023, then soared by 1430.77% to $54.1 million in 2024, then plummeted by 64.49% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Net Cash Flow are $19.2 million (Q4 2025), -$2.6 million (Q3 2025), and $7.2 million (Q2 2025).